Annual Retained Earnings
-$360.21 M
-$115.55 M-47.23%
December 31, 2024
Summary
- As of March 12, 2025, TARS annual retained earnings is -$360.21 million, with the most recent change of -$115.55 million (-47.23%) on December 31, 2024.
- During the last 3 years, TARS annual retained earnings has fallen by -$313.54 million (-671.79%).
- TARS annual retained earnings is now -26308.36% below its all-time high of -$1.36 million, reached on December 31, 2018.
Performance
TARS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$360.21 M
-$23.11 M-6.86%
December 31, 2024
Summary
- As of March 12, 2025, TARS quarterly retained earnings is -$360.21 million, with the most recent change of -$23.11 million (-6.86%) on December 31, 2024.
- Over the past year, TARS quarterly retained earnings has stayed the same.
- TARS quarterly retained earnings is now -5869.67% below its all-time high of -$6.03 million, reached on December 31, 2019.
Performance
TARS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TARS Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -47.2% | 0.0% |
3 y3 years | -671.8% | 0.0% |
5 y5 years | -5869.7% | 0.0% |
TARS Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -671.8% | at low | -671.8% | at low |
5 y | 5-year | -5869.7% | at low | -5869.7% | at low |
alltime | all time | <-9999.0% | at low | -5869.7% | at low |
Tarsus Pharmaceuticals Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$360.21 M(+47.2%) | -$360.21 M(+6.9%) |
Sep 2024 | - | -$337.10 M(+7.5%) |
Jun 2024 | - | -$313.68 M(+11.9%) |
Mar 2024 | - | -$280.39 M(+14.6%) |
Dec 2023 | -$244.66 M(+124.9%) | -$244.66 M(+20.7%) |
Sep 2023 | - | -$202.75 M(+23.9%) |
Jun 2023 | - | -$163.61 M(+23.8%) |
Mar 2023 | - | -$132.18 M(+21.5%) |
Dec 2022 | -$108.76 M | -$108.76 M(+14.3%) |
Sep 2022 | - | -$95.16 M(+31.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | -$72.65 M(+8.6%) |
Mar 2022 | - | -$66.91 M(+43.4%) |
Dec 2021 | -$46.67 M(+42.1%) | -$46.67 M(+46.7%) |
Sep 2021 | - | -$31.82 M(+97.4%) |
Jun 2021 | - | -$16.12 M(-28.2%) |
Mar 2021 | - | -$22.47 M(-31.6%) |
Dec 2020 | -$32.84 M(+444.3%) | -$32.84 M(+53.6%) |
Sep 2020 | - | -$21.38 M(+90.2%) |
Jun 2020 | - | -$11.24 M(+86.3%) |
Dec 2019 | -$6.03 M(+342.4%) | -$6.03 M |
Dec 2018 | -$1.36 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?
- What is Tarsus Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?
What is Tarsus Pharmaceuticals annual retained earnings?
The current annual retained earnings of TARS is -$360.21 M
What is the all time high annual retained earnings for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual retained earnings is -$1.36 M
What is Tarsus Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, TARS annual retained earnings has changed by -$115.55 M (-47.23%)
What is Tarsus Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of TARS is -$360.21 M
What is the all time high quarterly retained earnings for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly retained earnings is -$6.03 M
What is Tarsus Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, TARS quarterly retained earnings has changed by $0.00 (0.00%)